Old Web
English
Sign In
Acemap
>
Paper
>
Glecaprevir and Pibrentasvir for 12 Weeks for HCV Genotype 1 Infection and Prior Direct‐acting Antiviral Treatment
Glecaprevir and Pibrentasvir for 12 Weeks for HCV Genotype 1 Infection and Prior Direct‐acting Antiviral Treatment
2017
Fred Poordad
Franco Felizarta
Armen Asatryan
Mark S. Sulkowski
Robert W. Reindollar
Charles S. Landis
Stuart C. Gordon
Steven L. Flamm
Michael W. Fried
David Bernstein
Chih-Wei Lin
Ran Liu
Sandra S. Lovell
Teresa I. Ng
Jens Kort
Federico Mensa
Keywords:
Virology
Diabetes mellitus
Hepatitis C virus
Glecaprevir
Genotype
Immunology
Medicine
Pibrentasvir
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
73
Citations
NaN
KQI
[]